ViperMed

What ViperMed does

ViperMed is a pharmaceutical-specialized marketing agency operating in Latin America, headquartered in Montevideo, Uruguay (legal entity Paso Lima SA) with a regional office in Santiago de Chile. The firm designs and executes omnichannel promotional campaigns for pharmaceutical laboratories, serving both prescription (RX) and over-the-counter (OTC) brands. Its core offering follows a three-stage methodology: pain point discovery, measurable-impact campaign design (including experience design, omnichannel actions, digital materials, clinical evidence pieces, and a metrics architecture), and joint execution with the client's laboratory team on a 45-day strategy launch timeline.

The company's technology layer consists of proprietary tools for omnichannel campaign design covering all relevant ecosystem actors (sales force, clinics, institutions, point of sale, doctors, and patients), clinical evidence material generation, and KPI capture for commercial impact measurement. Its service portfolio is branded around "Impact 360" strategy and includes differentiated offerings for product launches, growth acceleration, and market leadership defense. The team comprises marketers, creatives, medical writers, physicians, designers, and engineers working in an orchestrated fashion.

ViperMed generates revenue through professional services engagements — primarily custom campaign design and ongoing monthly campaign management. Pricing is quote-based and not publicly disclosed. Go-to-market relies on direct B2B enterprise engagement with pharmaceutical marketing and sales leadership across LATAM, supplemented by a minimal digital presence (LinkedIn, industry awards, and case-study consultations). Named clients include GSK, Novartis Chile, Boehringer Ingelheim, Sandoz, Teva, Asofarma, Bago, and Megalabs. The company was founded in 2013 (per detailed company history; firmographics cite 2011), operates with 1-10 employees, and has raised $40,000 in disclosed funding (Start-Up Chile, June 2014).

Name

ViperMed

Legal name

Paso Lima SA

Website

https://vipermed.org

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

ViperMed is a Uruguay-headquartered (Montevideo) pharmaceutical marketing agency with a Santiago de Chile office, designing omnichannel promotional campaigns for prescription and OTC brands across Latin America. It serves enterprise pharmaceutical laboratories including GSK, Novartis, Boehringer Ingelheim, Sandoz, and Teva.

Ownership category

akta.pro rank

Product category

Pharmaceutical Marketing Services

NAICS

Advertising Agencies (541810)

akta.pro primary industry

B2B/ABM Creative Agencies (MPAAAAAI)

Keywords

• Pharmaceutical marketing
• Promotional campaign design
• Omnichannel marketing
• Disease awareness campaigns
• Brand strategy services

Headquarters

HQ city

Santiago

HQ country

Chile

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Campaign Design Services: Custom campaign strategy development, creative design, omnichannel implementation, and execution services for pharmaceutical brands
2. Ongoing Campaign Management: Monthly analysis and optimization of campaign impact to ensure return on investment

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

ViperMed is a B2B pharmaceutical marketing agency that designs and executes creative promotional campaigns for pharmaceutical laboratories across Latin America. Its Impact 360 strategy delivers omnichannel coverage targeting sales force, clinics, institutions, point of sale, doctors, and patients. Services include pain-point discovery, measurable-impact campaign design with digital pieces and clinical evidence materials, and joint execution with the laboratory's team including monthly impact analysis.

Product overview

ViperMed is a promotional campaign agency for pharmaceutical products operating as a single integrated service offering rather than a software platform. The company provides a three-stage methodology encompassing pain point discovery, measurable-impact campaign design, and full execution. Their core services include Impact 360 strategy covering sales force, clinics, institutions, point of sale, doctors, and patients; promotional campaign design with omnichannel capabilities; and clinical evidence materials. Services are differentiated for RX (prescription) and OTC (over-the-counter) pharmaceutical products, with specialized offerings for product launches, growth acceleration, and market leadership maintenance.

Differentiator

Problem solved

Functional benefit

Products and services

• Promotional Campaign Design Service

Quantifiable outcome

• 45-day strategy design and launch
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Publicis Health: Global healthcare communications network within Publicis Groupe offering pharmaceutical promotional campaigns, disease awareness and omnichannel strategy — the same core service ViperMed provides but at vastly greater geographic and scale.
• DDB Health: Omnicom's healthcare creative network offering pharmaceutical brand promotion, medical education and omnichannel strategy — overlapping service portfolio with ViperMed, particularly for RX product launches.
• Saatchi & Saatchi Wellness: Publicis Groupe health and wellness creative agency providing consumer and OTC pharma marketing — overlapping with ViperMed's OTC segment and consumer-engagement capabilities.
• TBWA\WorldHealth: Omnicom global health creative network focused on pharma brand strategy, launch and disease awareness — directly comparable offering to ViperMed's Impact 360 RX/OTC launch services.
• Ogilvy Health: WPP-owned health and pharma advertising agency delivering creative, medical education and omnichannel campaigns to pharma clients globally — directly comparable service mix and customer base to ViperMed.
• Havas Health & You: Havas-owned global health and wellness network providing pharma marketing, disease awareness and omnichannel campaign services — directly comparable to ViperMed's pharma-specialist agency offering.
• VMLY&R Health: WPP's healthcare specialist combining creative, data and technology for pharma brand campaigns — comparable to ViperMed's integrated omnichannel and KPI-measurement value proposition.
• McCann Health: Global healthcare agency network under IPG/Interpublic offering creative, medical communications and patient engagement to pharma — overlapping pharma promotional services with ViperMed's Impact 360 model.

Broad incumbents

• Megalabs: Latin American pharmaceutical company named as a former client contact (Sergio Fazio, Ex Director of Marketing, Megalabs Global); represents the customer-side incumbent and a potential in-sourcing threat to ViperMed's agency model.

Regional players

• Ponce (Latin American agency): Argentine-founded regional creative agency with deep LATAM pharma and consumer health credentials — most directly comparable regional peer to ViperMed by geography and pharma specialization.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/vipermed
• Xx.com/ViperMedUY
• Facebookfacebook.com/ViperMedUy

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ViperMed